EPA:DIM Sartorius Stedim Biotech Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sartorius Stedim Biotech S.A. Please log in to your account or sign up in order to add this asset to your watchlist. €297.40 -6.10 (-2.01%) (As of 06/29/2022 12:00 AM ET) Add Compare Share Today's Range€289.30▼€300.2050-Day Range€276.70▼€344.9052-Week Range N/AVolume47,681 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice Target€454.00 ProfileAnalyst RatingsChartCompetitorsHeadlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive DIM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address DIM Stock Forecast (MarketRank)Overall MarketRank™1.25 out of 5 starsAnalyst Opinion: 2.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 - 2.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of €454.00, Sartorius Stedim Biotech has a forecasted upside of 52.7% from its current price of €297.40.Amount of Analyst CoverageSartorius Stedim Biotech has received no research coverage in the past 90 days. Previous Next 4.3 Community Rank Outperform VotesSartorius Stedim Biotech has received 34 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSartorius Stedim Biotech has received 19 “underperform” votes. (Add your “underperform” vote.)Community SentimentSartorius Stedim Biotech has received 64.15% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Sartorius Stedim Biotech and other stocks. Vote “Outperform” if you believe DIM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DIM will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSartorius Stedim Biotech does not currently pay a dividend.Dividend GrowthSartorius Stedim Biotech does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sartorius Stedim Biotech insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next See Top Rated MarketRank™ Stocks Here About Sartorius Stedim Biotech (EPA:DIM)Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.Read More DIM Stock News HeadlinesJune 26, 2022 | americanbankingnews.comSartorius Stedim Biotech (EPA:DIM) Trading Up 1%June 16, 2022 | marketwatch.comWhat causes the Single Use Assemblies market giants to increase their spending by 2028?May 23, 2022 | benzinga.comLateral Flow Assay Components Market worth $420 million by 2027 – Global Trends, Share and Leading Key PlayersMay 9, 2022 | seekingalpha.comSartorius AG: Buy The French Subsidiary InsteadApril 21, 2022 | finance.yahoo.comFirst-quarter results 2022 of Sartorius Stedim BiotechApril 21, 2022 | finance.yahoo.comSartorius records dynamic start to the new fiscal yearFebruary 17, 2022 | finance.yahoo.comSartorius Stedim Biotech presents annual report for 2021February 8, 2022 | finance.yahoo.comSartorius Stedim Biotech completes acquisition of Novasep's chromatography divisionJanuary 27, 2022 | markets.businessinsider.comPreliminary results 2021 of Sartorius Stedim BiotechJanuary 7, 2022 | finanznachrichten.deSartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim BiotechJanuary 5, 2022 | finanznachrichten.deSartorius Stedim Biotech SA: Half-year liquidity -2-December 9, 2021 | benzinga.comSingle-use Bioprocessing Market Worth $20.8 billion – Worldwide Emerging Trends, Key Players and Growth OpportunitiesDecember 6, 2021 | marketwatch.comAseptic Sampling System Market Share 2021 : Industry Size with Sale, Growth Rate and Future Opportunity with Dominant Regions and Countries DataSee More Headlines Industry, Sector and Symbol Stock ExchangeEPA Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolEPA:DIM CUSIPN/A CIKN/A Webwww.sartorius.com Phone33 4 42 84 56 00FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Forecast€454.00 High Stock Price Forecast€454.00 Low Stock Price Forecast€454.00 Forecasted Upside/Downside+52.7%Consensus RatingN/A Rating Score (0-4)3 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Sartorius Stedim Biotech Frequently Asked Questions What is Sartorius Stedim Biotech's stock price forecast for 2022? 0 brokerages have issued 1 year target prices for Sartorius Stedim Biotech's stock. Their DIM stock forecasts range from €454.00 to €454.00. On average, they expect Sartorius Stedim Biotech's stock price to reach €454.00 in the next year. This suggests a possible upside of 52.7% from the stock's current price. View analysts' price targets for Sartorius Stedim Biotech or view top-rated stocks among Wall Street analysts. How has Sartorius Stedim Biotech's stock performed in 2022? Sartorius Stedim Biotech's stock was trading at €482.40 at the beginning of the year. Since then, DIM shares have decreased by 38.3% and is now trading at €297.40. View the best growth stocks for 2022 here. Who are Sartorius Stedim Biotech's key executives? Sartorius Stedim Biotech's management team includes the following people: Dr. Joachim Kreuzburg, Chairman & CEO (Age 57, Pay $891k)Mr. Heiko Imöhl, VP of Group Financing & Investor RelationsMs. Petra Kirchhoff, Head of Corp. Communications & IR (Age 53)Mr. John Gerard Mackay, Exec. VP of Marketing, Sales & Services for Lab Products and Services Division (Age 60)Benedikt Orzelek, Head of Investor RelationsOlivier Guitard, Head of Controlling BPS Who are some of Sartorius Stedim Biotech's key competitors? Some companies that are related to Sartorius Stedim Biotech include 4DMedical (4DX), Adherium (ADR), Allegra Orthopaedics (AMT), Analytica (ALT), AnteoTech (ADO), Anteris Technologies (AVR), Atomo Diagnostics (AT1), AVITA Medical (AVH), Azure Healthcare Limited (AZV.AX) (AZV), BICO Group AB (publ) (CLLKF), Cannabix Technologies (BLO), CleanSpace (CSX), Cochlear (COH), Cochlear (CHEOY) and Cochlear (CHEOF). View all of DIM's competitors. What other stocks do shareholders of Sartorius Stedim Biotech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius Stedim Biotech investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE), Apellis Pharmaceuticals (APLS), Aquantia (AQ) and Aquinox Pharmaceuticals (AQXP). What is Sartorius Stedim Biotech's stock symbol? Sartorius Stedim Biotech trades on the EPA under the ticker symbol "DIM." What is Sartorius Stedim Biotech's stock price today? One share of DIM stock can currently be purchased for approximately €297.40. How many employees does Sartorius Stedim Biotech have? Sartorius Stedim Biotech employs 10,409 workers across the globe. How can I contact Sartorius Stedim Biotech? The official website for Sartorius Stedim Biotech is www.sartorius.com. The company can be reached via phone at 33 4 42 84 56 00. This page (EPA:DIM) was last updated on 6/30/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
